Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs | The Journal of Rheumatology
TERIFLUNOMIDE
Apremilast (Otezla) approved by FDA • Johns Hopkins Arthritis Center